Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer
January 31, 2022 16:05 ET
|
Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc., (Nasdaq: LYEL), a T-cell reprogramming company dedicated to the mastery of T cells to cure patients with...
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
January 26, 2022 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick...
OcyonBio Appoints Daniel Chang, CPA, MBA, CPMP, CPIM as Chief Financial Officer
January 25, 2022 09:00 ET
|
OcyonBio (ocyonbio.com)
AGUADILLA, Puerto Rico, Jan. 25, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC announces it has appointed Daniel Chang Chief Financial Officer. OcyonBio is creating a contract development and manufacturing...
Global Viral Vectors for Cell Therapy Market Research Report 2022: Demographic Trends, New Developments, Cell and Gene Therapy Advancements, Company Performance Trends, M&As
January 19, 2022 06:38 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities" report has been added to ResearchAndMarkets.com's offering. All market data...
Global CAR T-cell Therapy Market (2021 to 2031) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts
January 18, 2022 06:58 ET
|
Research and Markets
Dublin, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to...
OcyonBio Appoints Robert Salcedo as Chief Executive Officer
January 06, 2022 16:00 ET
|
OcyonBio
AGUADILLA, Puerto Rico, Jan. 06, 2022 (GLOBE NEWSWIRE) -- OcyonBio, LLC is creating cell and gene therapy partnership development and manufacturing organization (PDMO). OcyonBio will provide...
Global Cell Therapy Technologies Market to Grow by a CAGR of 13.6% During 2021-2030 and Reach a Revenue of USD 45754.6 Million by 2030; Growing Prevalence of Chronic Diseases Worldwide to Drive Market Growth
January 06, 2022 07:15 ET
|
Kenneth Research
New York, Jan. 06, 2022 (GLOBE NEWSWIRE) -- According to the statistics by the World Health Organization (WHO), in the year 2020, deaths caused due to cancer registered close to 10 Million....
Intellia Therapeutics and Kyverna Therapeutics Announce Collaboration to Develop Next-Generation Allogeneic T-Cell Therapy for Autoimmune Diseases
January 05, 2022 07:30 ET
|
Intellia Therapeutics, Inc.
— Intellia grants Kyverna exclusive rights to its differentiated allogeneic cell engineering platform for the development of KYV-201, a next-generation CD19 CAR T-cell therapy to treat autoimmune...
Lyell Immunopharma to Participate in 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 16:05 ET
|
Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc., (NASDAQ: LYEL), a T-cell reprogramming company dedicated to the mastery of T cells to cure patients with...
Insights on the Translational Regenerative Medicine Global Market to 2026 - Featuring Anika Therapeutics, Celgene and Medipost Among Others
January 04, 2022 07:28 ET
|
Research and Markets
Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Translational Regenerative Medicine Market Research Report by Product Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of...